Test Price
450 AED✅ Home Collection Available
CD103 Immunohistochemistry (IHC) Test in UAE | 450 AED | 2026 DHA Guidelines
تحليل الكيمياء النسيجية المناعية CD103 في الإمارات | 450 درهم | معتمد من هيئة الصحة بدبي
Executive Summary / ملخص تنفيذي
دقة تشخيصية تصل إلى 99.9% باستخدام تقنية الكيمياء النسيجية المناعية وفقًا لمعايير ISO، مع خدمة سحب منزلي معتمدة ونقل مبرد لضمان سلامة العينة وتوجيه طبي هاتفي بعد النتيجة.
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited IHC processing with CD103 monoclonal antibody specificity.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM daily).
Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by DHA-licensed consultants.
Direct Billing & Insurance Verification:
Verify Coverage via WhatsApp+971 54 548 8731
Secure WhatsApp support for insurance pre-approval and billing.
Test Overview
The CD103 Immunohistochemistry test detects CD103 (integrin αEβ7) expression on tumor cells in formalin-fixed paraffin-embedded (FFPE) tissue, critical for classifying haematological malignancies such as hairy cell leukaemia and certain T‑cell lymphomas. يكتشف تحليل CD103 بالكيمياء النسيجية المناعية بروتين CD103 في أنسجة الورم المثبتة بالفورمالين، وهو أساسي لتشخيص لوكيميا الخلايا المشعرة وأنواع من الأورام اللمفاوية.
| Feature | Our CD103 IHC Test | Closest Alternative (Standard IHC Panel) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity, CD103-specific monoclonal antibody with DAB chromogen detection | ~90% sensitivity, relies on pan‑lymphoid markers without CD103 confirmation |
| Methodology | Advanced IHC on FFPE blocks with automated Ventana/Leica platforms, ISO 9001:2015 accredited | Manual or semi‑automated IHC, laboratory‑specific protocols |
| Turnaround Time | 5 days (tissue biopsy) / 7 days (large complex resections) | 7–10 working days |
| Sample Requirement | Tumor tissue in 10% formal‑saline OR FFPE block; histopathology report, biopsy site & clinical history mandatory | FFPE block only; limited clinical correlation |
Physician Insight & Safety Protocol
“As a haematopathologist with decades of experience, I emphasise that a CD103‑positive IHC result must be correlated with morphology, flow cytometry, and clinical findings before reaching a definitive diagnosis. Never alter treatment based solely on a single stain; always involve a multidisciplinary team. Your safety is paramount.” – Dr. Prabhakar Reddy, DHA License 61713011
‼ Medication Warning
Do not discontinue any prescribed medication or change therapeutic regimens without consulting your treating physician. CD103 IHC results are a diagnostic aid, not a treatment directive.
Exclusion Criteria & ER Red Flags
- Exclusion: Insufficient tumour cellularity (<100 viable tumour cells) or necrotic tissue in the submitted block; decalcified samples (e.g., bone marrow trephine) may cause false‑negative staining.
- Exclusion: Specimen not fixed in 10% neutral buffered formalin; prolonged fixation >72 hours leads to antigen masking.
- Red Flag: Sudden onset of severe fatigue, high fever >38.5°C, or unexplained bleeding/bruising while awaiting results – seek emergency care immediately.
- Red Flag: Rapidly enlarging lymph nodes or organomegaly with B‑symptoms (night sweats, weight loss) – report to your oncologist urgently.
UAE Regulatory & Accreditation Compliance
- Facility licensed by DHA/MOHAP: License No. 9834453
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
- All procedures adhere to Federal Decree-Law No. 41 of 2024 (Art. 87) on patient safety, UAE CDS Law 2026 (Minors), and UAE PDPL (Data Privacy)
- Sample collection performed by DHA‑licensed phlebotomists under strict cold‑chain protocols
Frequently Asked Questions
Q1: What does a positive CD103 IHC result indicate for my lymphoma diagnosis?
A positive CD103 immunostaining typically supports a diagnosis of hairy cell leukaemia or a subset of splenic marginal zone lymphomas, but the final diagnosis requires integration of full histomorphology, flow cytometry, and clinical history—this sensitive and specific marker helps differentiate from other low‑grade B‑cell neoplasms.
Q2: Why is the histopathology report and biopsy site mandatory before testing?
The histopathology report provides essential morphological context and prior IHC results, enabling our pathologists to select optimal antibody clones and interpret staining patterns accurately, thereby avoiding diagnostic errors and ensuring the result is clinically actionable.
Q3: Can I have the blood collection for this done at home, and how soon can I expect results?
Home collection is not applicable for tissue‑based CD103 IHC; a biopsy must be performed in a hospital or clinic, and the formalin‑fixed tissue or paraffin block is collected by our logistics team. Once received, your report is available within 5 days for standard biopsies and 7 days for large complex specimens, with same‑day electronic delivery.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians